1-4 of 4
Giuliana Alimena, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myelodysplastic Syndrome Patients Younger Than 50 Years: Epidemiological Data and Clinical Features

Massimo Breccia, PhD, Paola Finsinger, Roberto Latagliata, MD, Laura Cannella, PhD, Giuseppina Loglisci, PhD, Mauro Nanni, PhD, Michelina Santopietro, PhD, Adriano Salaroli, PhD, Agostino Tafuri, Giuliana Alimena, PhD
Journal: Blood
Blood (2010) 116 (21): 4976.
https://doi.org/10.1182/blood.V116.21.4976.4976
Published: 2010
Journal Articles

Decisional Flow with a Score System To Start Platelet-Lowering Treatment in Patients with Essential Thrombocythemia (ET): Long-Term Results.

Roberto Latagliata, MD, Angela Rago, MD, Antonio Spadea, MD, Cristina Santoro, MD, Ida Carmosino, MD, Massimo Breccia, MD, Laura Napoleone, MD, Angelo Fama, MD, Francesca Biondo, MD, Paola Volpicelli, MD, Maria Concetta Petti, PhD, Giuliana Alimena, PhD, Maria Gabriella Mazzucconi, PhD
Journal: Blood
Blood (2007) 110 (11): 4636.
https://doi.org/10.1182/blood.V110.11.4636.4636
Published: 2007
Journal Articles

Long Term Follow-Up of the Gimema GSI 103 AMLE Randomized Trial: Daunoxome Seems To Improve Disease-Free Survival (DFS) of Elderly Patients with Acute Myelogenous Leukemia (AML).

Roberto Latagliata, MD, Massimo Breccia, MD, Simona Iacobelli, Paola Fazi, MD, Giovanni Martinelli, MD, Francesco Di Raimondo, MD, Marco Sborgia, MD, Francesco Fabbiano, MD, Francesco Lauria, PhD, Eliana Zuffa, MD, Adriano Venditti, PhD, Monica Crugnola, MD, Antonio Peta, MD, Anna Candoni, MD, Daniela Cilloni, MD, Enrico Mattei, MD, Monica Morselli, MD, Domenico Pastore, MD, Francesca Adamo, MD, Antonia Centra, MD, Franca Falzetti, MD, Marco Vignetti, MD, Giuliana Alimena, PhD, Franco Mandelli, PhD
Journal: Blood
Blood (2006) 108 (11): 1979.
https://doi.org/10.1182/blood.V108.11.1979.1979
Published: 2006
Journal Articles

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Roberto Latagliata, MD, Massimo Breccia, MD, Ida Carmosino, MD, Chiara Sarlo, MD, Rosa De Cuia, MD, Marco Mancini, MD, Francesca Biondo, MD, Eleonora Russo, MD, Annalisa De Vellis, MD, Daniela Diverio, MD, Franco Mandelli, PhD, Giuliana Alimena, PhD
Journal: Blood
Blood (2004) 104 (11): 4693.
https://doi.org/10.1182/blood.V104.11.4693.4693
Published: 2004